Zobrazeno 1 - 10
of 150
pro vyhledávání: '"José M Serratosa"'
Autor:
Mar Carreño, Antonio Gil‐Nagel, José M. Serratosa, Manuel Toledo, Juan Jesus Rodriguez‐Uranga, Vicente Villanueva
Publikováno v:
Epilepsia Open, Vol 9, Iss 3, Pp 1051-1058 (2024)
Abstract Objective Cenobamate is an antiseizure medication (ASM) associated with high rates of seizure freedom and acceptable tolerability in patients with focal seizures. To achieve the optimal cenobamate dose for maximal potential effectiveness whi
Externí odkaz:
https://doaj.org/article/a918501ee9b846fbb730989b8c291bc6
Autor:
Matthias J. Koepp, Eugen Trinka, Yee‐Haur Mah, Carla Bentes, Susanne Knake, Gian Luigi Gigli, José M. Serratosa, Johan Zelano, Luís M. Magalhães, Ana Pereira, Joana Moreira, Patrício Soares‐da‐Silva
Publikováno v:
Epilepsia Open, Vol 8, Iss 3, Pp 1190-1201 (2023)
Abstract There is currently no evidence to support the use of antiseizure medications to prevent unprovoked seizures following stroke. Experimental animal models suggested a potential antiepileptogenic effect for eslicarbazepine acetate (ESL), and a
Externí odkaz:
https://doaj.org/article/1816a04c78354f59ba86372099a6f80a
Autor:
Daniel F. Burgos, Miriam Sciaccaluga, Carolyn A. Worby, Luis Zafra-Puerta, Nerea Iglesias-Cabeza, Gema Sánchez-Martín, Paolo Prontera, Cinzia Costa, José M. Serratosa, Marina P. Sánchez
Publikováno v:
Neurobiology of Disease, Vol 181, Iss , Pp 106119- (2023)
Lafora disease is a rare recessive form of progressive myoclonic epilepsy, usually diagnosed during adolescence. Patients present with myoclonus, neurological deterioration, and generalized tonic-clonic, myoclonic, or absence seizures. Symptoms worse
Externí odkaz:
https://doaj.org/article/1ed534af11534c5980ce7b80c1642e34
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Beatriz G. Giraldez, José M. Serratosa, Salvatore Striano, Akio Ikeda, Pasquale Striano, Antonietta Coppola
Publikováno v:
Epilepsia.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9ede74904d8538d04f2bba28266f465
https://doi.org/10.1111/epi.17595
https://doi.org/10.1111/epi.17595
Autor:
Matthias J. Koepp, Eugen Trinka, Yee‐Haur Mah, Carla Bentes, Susanne Knake, Gian Luigi Gigli, José M. Serratosa, Johan Zelano, Luís M. Magalhães, Ana Pereira, Joana Moreira, Patrício Soares‐da‐Silva
Publikováno v:
Epilepsia Open.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cfa170a58ce53b4743570e87dfe48b39
https://doi.org/10.1002/epi4.12735
https://doi.org/10.1002/epi4.12735
Autor:
Daniel F. Burgos, Lorena Cussó, Gentzane Sánchez-Elexpuru, Daniel Calle, Max Bautista Perpinyà, Manuel Desco, José M. Serratosa, Marina P. Sánchez
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 20, p 7771 (2020)
Mutations in the EPM2A and EPM2B genes, encoding laforin and malin proteins respectively, are responsible for Lafora disease, a fatal form of progressive myoclonus epilepsy with autosomal recessive inheritance. Neuroimaging studies of patients with L
Externí odkaz:
https://doaj.org/article/7d24b5f2c6e341668e1b2c1c74734cde
Autor:
Vicente Villanueva, José M. Serratosa, Manuel Toledo, Miguel Ángel Calleja, Andrés Navarro, Joel Sabaniego, Paloma Pérez-Domper, Elena Álvarez-Barón, Silvia Subías, Alicia Gil
Publikováno v:
Scientia
Medicamentos anticonvulsivos; Cenobamato; Eficiencia Medicaments anticonvulsius; Cenobamat; Eficiència Anti-seizure medications; Cenobamate; Efficiency Introduction Epilepsy is a serious neurological disease, ranking high in the top causes of disabi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18d0a76f3f36280879d4df7c28bddc2b
https://pubmed.ncbi.nlm.nih.gov/36603345
https://pubmed.ncbi.nlm.nih.gov/36603345
Autor:
Bernhard J. Steinhoff, Elinor Ben‐Menachem, Christian Brandt, Irene García Morales, William E. Rosenfeld, Estevo Santamarina, José M. Serratosa
Publikováno v:
Scientia
Cenobamate; Drug-resistant epilepsy; Seizures Cenobamato; Epilepsia resistente a los medicamentos; Convulsiones Cenobamat; Epilèpsia resistent a medicaments; Convulsions Objectives Cenobamate is an antiseizure medication (ASM) approved in Europe as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8b5ce9778ed19d59302309a47e50948
https://hdl.handle.net/11351/8121
https://hdl.handle.net/11351/8121
Autor:
Laura Ortega-Moreno, Beatriz G Giráldez, Victor Soto-Insuga, Rebeca Losada-Del Pozo, María Rodrigo-Moreno, Cristina Alarcón-Morcillo, Gema Sánchez-Martín, Esther Díaz-Gómez, Rosa Guerrero-López, José M Serratosa, Grupo Español de Genética de las Epilepsias de la Infancia (GEGEI)
Publikováno v:
PLoS ONE, Vol 12, Iss 11, p e0188978 (2017)
Pediatric epilepsies are a group of disorders with a broad phenotypic spectrum that are associated with great genetic heterogeneity, thus making sequential single-gene testing an impractical basis for diagnostic strategy. The advent of next-generatio
Externí odkaz:
https://doaj.org/article/b84d39a5a3a147318bfb64d9bc4a2963